Cabco Tr Jcp 7.625

(HEB) Trade

By |

Profile

Hemispherx Biopharma Inc is a specialty pharmaceutical company. It is primarily engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune-based disorders.

Contact Information

Website: www.hemispherx.net
Email: info@hemispherx.net
Main Phone: +1 631 587-4700
Address: 68 South Service Road
Address 2: Suite 120
State: NY
City / Town: Melville
Country: USA
Postal Code: 11747

Issuer Information

Exchange: NYE
CEO: Thomas K. Equels
Employees: 27
NAICS: Sales Financing (522220)
$ 0.33 $ 0.0114 (3.60%)
Last Price 0.33 Change $ 0.0114 Change % 3.60 Tick N/A
Bid 0.33 Bid Size 500.00 Ask 0.33 Ask Size 5,100.00
Open 0.33 High 0.34 Low 0.32 Prev Close 0.32
Last Trade Volume 418,832 52 Wk Hi 0.74 52 Wk Low 0.28
Market Cap 15.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 46,202,997.00 EPS (TTM) -0.25 PE Ratio N/A Exchange NYSE American
  Last 3 Mo Last 12 Mo
Number of Insider Trades 18 54
Number of Buys 18 54
Number of Sells 0 0
Net Activity 2115274 3796128
Last 10 Buys Shares
Stewart L. Appelrouth 1,000
Thomas K. Equels 1,000
David R. Strayer 1,000
Adam Pascale 1,000
Wayne S. Springate 1,000
Peter W. Rodino 1,000
Thomas K. Equels 1,000
Thomas K. Equels 1,000
Adam Pascale 1,000
David R. Strayer 1,000
Last 10 Sell Shares
William A. Carter 1,000
William A. Carter 1,000
William A. Carter 1,000
William A. Carter 1,000
David R. Strayer 1,000
David R. Strayer 1,000
David R. Strayer 1,000
Charles T. Bernhardt 1,000
Wayne S. Springate 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3 3 3 3
Low Target Price Estimate 3 3 3 3
Mean Target Price Estimate 3 3 3 3
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 01/21/14 01/21/14 01/21/14 01/21/14
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1